GB0411052D0 - Method of producing human beta cell lines - Google Patents

Method of producing human beta cell lines

Info

Publication number
GB0411052D0
GB0411052D0 GBGB0411052.4A GB0411052A GB0411052D0 GB 0411052 D0 GB0411052 D0 GB 0411052D0 GB 0411052 A GB0411052 A GB 0411052A GB 0411052 D0 GB0411052 D0 GB 0411052D0
Authority
GB
United Kingdom
Prior art keywords
human beta
pancreatic
beta cell
cell lines
producing human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0411052.4A
Other versions
GB2397825B (en
GB2397825A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Paris Diderot Paris 7
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Paris Diderot Paris 7
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Paris Diderot Paris 7 filed Critical Centre National de la Recherche Scientifique CNRS
Publication of GB0411052D0 publication Critical patent/GB0411052D0/en
Publication of GB2397825A publication Critical patent/GB2397825A/en
Application granted granted Critical
Publication of GB2397825B publication Critical patent/GB2397825B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0678—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Abstract

The invention provides a method of regenerating pancreas function in an individual by transplantation of an effective amount of functional pancreatic cells derived from embryonic pancreatic cells not older than 10 weeks of development. Also provided is the method of producing functional animal pancreatic cell, more precisely an immortalized human beta cell line. The invention also provides a method of treatment of diabetics. Also are provided pancreatic beta cells as a medicament to treat diabetics.
GB0411052A 2001-10-19 2002-10-18 Method of producing human beta cell lines Expired - Lifetime GB2397825B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/981,750 US20030077256A1 (en) 2001-10-19 2001-10-19 Pancreas regeneration using embryonic pancreatic cells
PCT/IB2002/004599 WO2003033685A2 (en) 2001-10-19 2002-10-18 Method of producing human beta cell lines

Publications (3)

Publication Number Publication Date
GB0411052D0 true GB0411052D0 (en) 2004-06-23
GB2397825A GB2397825A (en) 2004-08-04
GB2397825B GB2397825B (en) 2006-02-22

Family

ID=25528625

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0411052A Expired - Lifetime GB2397825B (en) 2001-10-19 2002-10-18 Method of producing human beta cell lines

Country Status (18)

Country Link
US (2) US20030077256A1 (en)
EP (1) EP1456356B1 (en)
JP (1) JP2005505635A (en)
KR (1) KR20040080430A (en)
CN (1) CN1662644A (en)
AT (1) ATE452967T1 (en)
BR (1) BR0213429A (en)
CA (1) CA2463979A1 (en)
DE (1) DE60234862D1 (en)
GB (1) GB2397825B (en)
HR (1) HRP20040446A2 (en)
HU (1) HUP0600102A2 (en)
IL (1) IL161468A0 (en)
NZ (1) NZ532965A (en)
PL (1) PL370167A1 (en)
RU (1) RU2004115108A (en)
WO (1) WO2003033685A2 (en)
ZA (1) ZA200403646B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910305B2 (en) * 2005-09-15 2011-03-22 The Burnham Institute For Medical Research Methods for screening for compounds that modulate insulin promoter activity
US10167450B2 (en) * 2007-02-21 2019-01-01 Sarl Endocells Human pancreatic beta cell lines for diagnostic of diabetes
US8859286B2 (en) * 2013-03-14 2014-10-14 Viacyte, Inc. In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
KR102580225B1 (en) 2013-06-11 2023-09-20 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
CN107614678B (en) 2014-12-18 2021-04-30 哈佛学院校长同事会 Method for producing stem cell-derived beta cells and method for using same
US10190096B2 (en) 2014-12-18 2019-01-29 President And Fellows Of Harvard College Methods for generating stem cell-derived β cells and uses thereof
US10443042B2 (en) 2014-12-18 2019-10-15 President And Fellows Of Harvard College Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof
EP3710021A4 (en) 2017-11-15 2021-08-11 Semma Therapeutics, Inc. Islet cell manufacturing compositions and methods of use
CA3108275A1 (en) 2018-08-10 2020-02-13 Vertex Pharmaceuticals Incorporated Stem cell derived islet differentiation
CN110029130A (en) * 2019-04-24 2019-07-19 皖南医学院第一附属医院（皖南医学院弋矶山医院） Sidt2 genetic method is rejected in Beta-TC-6 cell strain based on CRISPR/Cas9 system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723333A (en) * 1995-02-10 1998-03-03 Regents Of The University Of California Human pancreatic cell lines: developments and uses

Also Published As

Publication number Publication date
IL161468A0 (en) 2004-09-27
ATE452967T1 (en) 2010-01-15
NZ532965A (en) 2006-04-28
PL370167A1 (en) 2005-05-16
EP1456356B1 (en) 2009-12-23
GB2397825B (en) 2006-02-22
GB2397825A (en) 2004-08-04
KR20040080430A (en) 2004-09-18
US20030219418A1 (en) 2003-11-27
ZA200403646B (en) 2005-01-26
CN1662644A (en) 2005-08-31
EP1456356A2 (en) 2004-09-15
DE60234862D1 (en) 2010-02-04
WO2003033685A2 (en) 2003-04-24
JP2005505635A (en) 2005-02-24
HUP0600102A2 (en) 2006-05-29
RU2004115108A (en) 2005-02-10
BR0213429A (en) 2004-11-09
HRP20040446A2 (en) 2005-04-30
WO2003033685A3 (en) 2004-05-27
US20030077256A1 (en) 2003-04-24
CA2463979A1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
AU2003208567A8 (en) Methods of inducing differentiation in stem cells, methods of generating tissue using scaffold matrices derived from micro-organs and stem cells, methods of producing adult stem cells and methods of continuously generating stem cells by implantation of micro-organs as sources of stem cells
DE69525151T2 (en) METHODS FOR DISEASE TREATMENT USING SERTOLI CELLS AND ALLOTRANSPLANT OR XENOTRANSPLANTAT
ATE348808T1 (en) AZACYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF SEROTONIN RELATED DISEASES
WO2008048663A3 (en) Novel process for devitalized/acellular tissue for transplantation
GB2397825B (en) Method of producing human beta cell lines
TR199903142T2 (en) CD154 blockade therapy for islet transplantation of pancreatic tissue.
AU6090799A (en) Transgenic c. elegans as a model organism for research into alzheimer's disease
HUP0101913A2 (en) Immortalised cell lines derived from normal human skin tissues
DE60039160D1 (en) USE OF ERBB RECEPTOR LIGANDS FOR THE TREATMENT OF DIABETES
DE60334534D1 (en) CHIMERIC PANCREAS
DK1237562T3 (en) Process for the preparation of micania extracts containing micanolide and dihydromycanolide and use in the treatment of proliferative diseases
AU2001245319A1 (en) Methods of treating diseases with activated protein c
IL137410A0 (en) A method for the production of transgenic plants using apical shoot tips
AP9801416A0 (en) Method Of treating a plant disease.
MXPA02002444A (en) Method for generating immune compatible cells and tissues using nuclear transfer techniques.
GB9907048D0 (en) Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
FR2801900B1 (en) METHOD FOR PRODUCING ADHERENT ANIMAL CELLS
ATE400661T1 (en) COMMERCIAL PRODUCTION OF CHYMOSIN IN PLANTS
BR9911211A (en) Method for inducing apoptosis in cells
ATE525463T1 (en) GENOMIC TOBACCO NICOTINE DEMETHYLASE CLONE AND USE
MX9709748A (en) Use of neuro-derived fetal cell lines for transplantation therapy.
UA39614A (en) Method for correcting functional state of myocardium in laboratory animals of late ontogenesis
WO2002040061A3 (en) Immunocompetent animals including xenogeneic implants of mesenchymal stem cells
ATE269090T1 (en) ANIMAL MODEL FOR TESTING DRUGS TO TREAT LEUKEMIA OR HIV
RU96122257A (en) METHOD FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20221017